[Effect of probiotics on respiratory tract pathogen colonization in neonates undergoing mechanical ventilation]

Area of Science:

• Neonatal critical care
• Microbiology
• Infectious disease prevention

Context:

• Neonates undergoing mechanical ventilation are at high risk for oropharyngeal and lower respiratory tract colonization by pathogenic bacteria.
• This colonization can lead to ventilator-associated pneumonia (VAP), a serious complication in this vulnerable population.
• Current preventative strategies have limitations, necessitating exploration of novel therapeutic approaches.

Purpose:

• To evaluate the efficacy of orally administered probiotics in reducing pathogenic bacterial colonization in the oropharynx and lower respiratory tract of neonates requiring mechanical ventilation.
• To assess the impact of probiotics on the incidence and timing of ventilator-associated pneumonia (VAP) in this patient group.
• To determine the safety profile of probiotic supplementation in mechanically ventilated neonates.

Summary:

• A randomized controlled trial involving 165 neonates undergoing mechanical ventilation demonstrated that oral probiotics significantly reduced pathogenic bacterial colonization rates in the oropharynx compared to the control group (35% vs. 51%, P<0.05).
• The probiotic group also experienced delayed colonization of pathogenic bacteria in both the oropharynx and lower respiratory tract, as well as a delayed onset of VAP (P<0.05).
• No adverse reactions were reported in the probiotic group, indicating a favorable safety profile.

Impact:

• Probiotic administration represents a promising strategy for preventing bacterial colonization and reducing the incidence of VAP in mechanically ventilated neonates.
• This intervention may lead to improved clinical outcomes and reduced healthcare burdens associated with VAP in neonatal intensive care units.
• Further research can explore optimal probiotic strains and dosages for maximizing benefits in neonatal critical care settings.